Comment j'explore...une tumeur cutanee chez un transplante.

Humans; Immunocompromised Host; Immunosuppressive Agents/administration & dosage/adverse effects; Organ Transplantation; Skin Neoplasms/diagnosis/immunology

Abstract :

[en] Immunosuppressive therapy associated with organ transplant leads to an increased risk to develop skin cancers. In such circumstances, squamous cell carcinomas and basal cell carcinomas represent the most frequent tumors. Other neoplasms include malignant melanoma, Merkel cell carcinoma and Kaposi disease. Histopathology is primordial in the establishment of the diagnosis. In addition, bioengineering devices and skin imaging methods are useful in establishing the risk of cancers and for detecting incipient tumoral lesions.

Disciplines :

Dermatology

Author, co-author :

QUATRESOOZ, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

REGINSTER, Marie-Annick ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

PAQUET, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard-Franchimont, Claudine ; Université de Liège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques

PIERARD, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

Comment j'explore...une tumeur cutanee chez un transplante.

Alternative titles :

[en] How I explore...a skin tumor in a transplant patient

Publication date :

2010

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

696-9

Peer reviewed :

Peer reviewed

Available on ORBi :

since 07 February 2018

Statistics

Number of views

80 (4 by ULiège)

Number of downloads

6 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Quatresooz P, Piérard GE, Paquet P, et al. - Cancers cutanés après transplantation d'organe, un revers de médaille. Rev Med Liège, 2007, 62, 663-668.
Paquet P, Piérard GE. - Invasive atypical fibroxanthoma and eruptive actinic keratoses in a heart transplant patient. Dermatology, 1996, 192, 411-413. (Pubitemid 26243993)
Euvrard S, Kanitakis J, Claudy A. - Skin cancers in organ transplant recipients. N Engl J Med, 2003, 348, 1681-1691. (Pubitemid 36459475)
Ulrich C, Kanitakis J, Stockfleth E, et al. - Skin cancer in organ transplant recipients- Where do we stand today? Am J Transplant, 2008, 8, 2192-2198.
Uhoda I, Quatresooz P, Fumal I, et al. - Updating trends in cutaneous cancers in south-east Belgium. Oncol Rep, 2004, 12, 111-114.
Piérard-Franchimont C, Piérard GE. - Héliodermie hétérochrome et risque de cancers cutanés. Rev Med Liège, 1998, 53, 355-356.
Quatresooz P, Uhoda I, Piérard-Franchimont C, Piérard GE. - Déterminisme multifactoriel de l'héliodermie. Publ Eska. Paris. E. Uhoda, M. Paye, G.E. Piérard. In: Actualités en Ingénierie Cutanée, 2006, 4, 43-50.
Lindelöf B, Sigurgeirsson B, Gäbel H, Stern RS. - Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol, 2000, 143, 513-519.
Ramsay HM, Fryer AA, Reece S, et al. - Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis, 2000, 36, 167-176.
Berg D, Otley C. - Skin cancer in organ transplant recipients : epidemiology, pathogenesis, and management. J Am Acad Dermatol, 2002, 47, 1-17.
Euvrard S, Kanitakis J, Decullier E, et al. - Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation, 2006, 81, 1093-1100.
Tan HE, Goh CL. - Viral infections affecting the skin in organ transplant recipients; epidemiology and current management strategies. Am J Clin Dermatol, 2006, 7, 13-29.
Bouwes-Bavinck JN, Euvrard S, Naldi L, et al. - Keratotic skin lesions and other risk factors are associated with skin cancer in organ transplant recipients : a case-control study in the Netherlands, United Kingdom, Germany, France and Italy. J Invest Dermatol, 2007, 127, 1647-1656.
Harwood CA, Surentheran T, McGregor J, et al. - Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol, 2000, 61, 289-297.
Berkhout R, Bouwes-Bavinck J, ter Schegget J. - Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol, 2000, 38, 2087-2096. (Pubitemid 30414320)
Cooper SM, Wojnorowska F. - The accuracy of clinical diagnostics of suspected premalignant and malignant skin lesions in renal transplant recipients. Clin Exp Dermatol, 2002, 27, 436-438.
Smoller BR. - Squamous cell carcinoma : from percursor lesions to high-risk variants. Modern Pathol, 2006, 19, S88-S92.
Quatresooz P, Piérard-Franchimont C, Paquet P, Piérard GE. - Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues. Eur J Dermatol, 2008, 18, 6-10.
Khanna M, Fortier-Riberdy G, Dinehart SM, et al. - Histopathologic evaluation of cutaneous squamous cell carcinoma : results of a survey among dermatopathologists. J Am Acad Dermatol, 2003, 48, 721-726. (Pubitemid 36583283)
Uhoda I, Quatresooz P, Piérard-Franchimont C, Piérard GE. - Nudging epidermal field cancerogenesis by imiquimod. Dermatology, 2003, 206, 357-360.
Piérard GE, Basset-Seguin N, Hengge U, et al. - Kératoses actiniques sous la loupe. Publ. Artoos, Bruxelles, 2009, 1-67.
Szepetiuk G, Xhauflaire-Uhoda E, Schreder A, et al. - Comment j'explore... la peau par le photodiagnostic utilisant la fluorescence cutanée et son imagerie fonctionnelle. Rev Med Liège, 65, 9, 521-526.
Fritsch C, Ruzicka T. - Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J Environ Pathol Toxicol Oncol, 2006, 25, 425-440.
Angell-Petersen E, Sorensen R, Warloe T, et al. - Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl-5-aminolevulinate. J Invest Dermatol, 2006, 126, 265-271.
Vereecken P, Da Costa CM, Steels E, et al. - Fluorescence diagnosis of face-located basal cell carcinomas: a new dermatological procedure which may help the surgeon. Acta Chir Belg, 2007, 107, 205-207.
Martin A, Tope WD, Grevelink JM, et al. - Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid : implications for photodynamic treatment. Arch Dermatol Res, 1995, 287, 665-674.
Xhauflaire-Uhoda E, Piérard GE, Quatresooz P. - The skin landscape following nonoptical capacitance imaging. Am J Clin Dermatol, 2010, 11, 89-94.
Quatresooz P, Xhauflaire-Uhoda E, Piérard-Franchimont C, et al. - Epidermal field carcinogenesis in bald-headed. An attempt at finetuning early noninvasive detection. Oncol Rep, 2009, 21, 1313-1316.
Xhauflaire-Uhoda E, Piérard-Franchimont C, Piérard GE, et al. - Weathering of the hairless scalp : a study using skin capacitance imaging and ultraviolet light-enhanced visualization. Clin Exp Dermatol, 2010, 35, 83-85.
Quatresooz P, Petit L, Uhoda I, et al. - Mosaic subclinical melanoderma. An Achilles heel for UV-related epidermal carcinogenesis ? Int J Oncol, 2004, 25, 1763-1767.
Quatresooz P, Piérard GE. - The Visioscan-driven ULEV and SELS methods. In : Handbook of Cosmetic Science and Technology, 3 ème édition. Barel AO, Paye M, Maibach HI (eds). Publ. Informa Healthcare, New York, USA, 2009, 283-290.